Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Protirelin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRHR known ✓ | P34981 | 6/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Protirelin SCHEMBL10087855 | 1.00 | TRHR (1.00) | TRHR | |
| Protirelin SCHEMBL10087946 | 1.00 | TRHR (1.00) | TRHR | |
| Protirelin SCHEMBL16091769 | 1.00 | TRHR (1.00) | TRHR | |
| Protirelin SCHEMBL4406163 | 0.97 | TRHR (0.93) | TRHR | |
| Protirelin SCHEMBL1007386 | 0.95 | TRHR (0.91) | TRHR | |
| SCHEMBL29539733 | 0.92 | TRHR (0.85) | TRHR | |
| Azetirelin SCHEMBL195158 | 0.92 | TRHR (0.85) | TRHR | |
| Protirelin SCHEMBL11309963 | 0.92 | TRHR (0.84) | TRHR | |
| SCHEMBL16072685 | 0.91 | TRHR (0.84) | TRHR | |
| SCHEMBL16088505 | 0.91 | TRHR (0.84) | TRHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11876 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | BHAMIS RES LABORATORY PVT LTD (IN) | 2026-05-07 | — | — | US | claimed |
| US-12533321-B2 | Polypeptide formulations for oral delivery | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2026-01-27 | — | — | US | claimed |
| EP-4631514-A1 | ORAL POLYPEPTIDE COMPOSITION AND USE THEREOF | Hefei Tianhui Biotech Co., Ltd. (CN) | 2025-10-15 | — | — | EP | claimed |
| EP-4601623-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2025-08-20 | — | — | EP | claimed |
| WO-2025118074-A1 | OLFACTORY DELIVERY OF THERAPEUTIC PEPTIDES | ROCKET SCIENCE HEALTH CORP. (CA) | 2025-06-12 | — | — | WO | claimed |
| EP-3661539-B1 | OPTIMIZED PEPTIDES FOR TARGETING HUMAN NERVES AND THEIR USE IN IMAGE GUIDED SURGERY, DIAGNOSTICS AND THERAPEUTIC DELIVERY | UNIV CALIFORNIA (US) | 2024-10-09 | — | — | EP | claimed |
| EP-2964658-B1 | POSITRON-EMITTING SUBSTITUTED ORGANOFLUOROBORATES AS IMAGING AGENTS | UNIV BRITISH COLUMBIA (CA) | 2024-08-07 | — | — | EP | claimed |
| WO-2024133655-A1 | PEST CONTROL COMPOSITION | Reckitt & Colman (Overseas) Hygiene Home Limited (GB) | 2024-06-27 | — | — | WO | claimed |
| CN-117899200-A | Medicament for enhancing curative effect of immunotherapy and application of medicament in treating tumors | 华中科技大学 | 2024-04-19 | — | — | CN | claimed |
| US-20240122860-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2024-04-18 | — | — | US | claimed |
| WO-1988000837-A2 | ADVANCED ANTICANCER THERAPY AND CYTOTOXIC MEDICAMENTS FOR ITS IMPLEMENTATION | BATTELLE MEMORIAL INSTITUTE (CH) | 1988-02-11 | — | — | WO | claimed |
| US-4707454-A | Fluorescent chlorophyll labeled assay reagents | BIO-DIAGNOSTICS, INC. (US) | 1987-11-17 | — | — | US | claimed |
| US-4670419-A | POLYPEPTIDE AND CYCLODEXTRIN | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1987-06-02 | — | — | US | claimed |
| US-4659696-A | MIXTURE OF POLYPEPTIDE AND CYCLODEXTRIN | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1987-04-21 | — | — | US | claimed |
| EP-0071991-B1 | IMPROVED FLUORO IMMUNO ASSAY SYSTEM | BIO-DIAGNOSTICS, INC. (US) | 1986-05-14 | — | — | EP | claimed |
| US-4426378-A | Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1984-01-17 | — | — | US | claimed |
| US-4374828-A | PEPTIDES, IMMUNE SYSTEM ENHANCEMENT | BOARD OF REAGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1983-02-22 | — | — | US | claimed |
| EP-0071991-A2 | Improved fluoro immuno assay system | BIO-DIAGNOSTICS, INC. (US) | 1983-02-16 | — | — | EP | claimed |
| US-4045556-A | ANTIDEPRESSANTS, PYSCHOSTIMULANTS; SILYLATION | SCHWERTNER EBERHARD | 1977-08-30 | — | — | US | claimed |
| US-3988307-A | ATTACHING AN ALPHA,BETA-UNSATURATED AMINO ACID TO A SOLID SUPPORT; ACIDIC AQUEOUS RELEASE AGENT | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) | 1976-10-26 | — | — | US | claimed |